Alberto's Corner (49th and 8th)

49th International Danube Neurology Symposium

American society of hematology 49th annual meeting.

In a clinical trial among 187 patients with paroxysmal nocturnal hemolysis (PNH), treatment with eculizumab (Soliris, Alexion), a terminal complement inhibitor, significantly reduced hemolysis and thrombosis and improved anemia and fatigue in several participating subgroups. Dr. Bessler noted that the disease burden had not previously been determined in these patients, who had lower lactate deh...

Reflections on the Boston Meeting from across the 49th Parallel.

A s a Canadian observer and participant, I offer the following opinions about the recently concluded Boston meeting concerning the morbidity and mortality of dialysis in the United States of America. First, I congratulate Americans for having the courage to execute a meeting that catalyzed a disturbing discussion about imperfect technologies and poor patient outcomes in their country. Thank you...

AllerGen’s 8th research conference

© The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if c...

Medical Electricity, 8th Edition